Impact of GLP-1 Receptor Agonists on Cardiovascular Risk Reduction in Patients with Type 2 Diabetes. Journal of Carcinogenesis, [S. l.], v. 24, n. 10s, p. 141–153, 2025. DOI: 10.64149/. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/1530. Acesso em: 6 dec. 2025.